Background: Effects of prolonged nevirapine prophylaxis exposure on growth among HIV-exposed uninfected (HEU) infants are unknown. This study examines the impact of extended nevirapine prophylaxis from 6 weeks to 6 months on the growth of HEU infants followed for 18 months and also identifies correlates of incident wasting, stunting, underweight, and low head circumference in the HPTN 046 trial. Methods: Intention-to-treat analysis examined the effect of extended nevirapine exposure on: weight-for-age Z-score, length-for-age Z-score, weight-for-length Z-score, and head circumference-for-age Z-score. Multivariable linear mixed-effects and Cox proportional hazard models were used to compare growth outcomes between the study arms and identi...
Uninfected children born to HIV-infected women are exposed antenatally to antiretroviral therapy, bu...
With expanded HIV treatment and prevention programmes, most infants born to HIV-positive women are u...
We analyzed the development of nevirapine (NVP) resistance in human immunodeficiency virus type 1 (H...
SummaryBackgroundNevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exp...
Background Nevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exposed ...
Latest World Health Organization guidelines recommend weight-based nevirapine prophylaxis for all HI...
Daily nevirapine (NVP) prophylaxis to HIV-exposed infants significantly reduces breast-milk HIV tran...
International audienceBackgroundThe tolerance of antiretroviral drugs in infants must be carefully e...
Background: The World Health Organization HIV guidelines recommend either infant zidovudine (ZDV) or...
Abstract Background India has among the highest rates of infant malnutrition. Few studies investigat...
Daily nevirapine (NVP) prophylaxis to HIV-exposed infants significantly reduces breast-milk HIV tran...
Data from a prospective multisite cohort study were used to examine the effect of HIV exposure, untr...
Background: India has among the highest rates of infant malnutrition. Few studies investigating the ...
Assess nevirapine (NVP) resistance in infants who became infected in the three arms of the Breastfee...
BACKGROUND There are concerns about the effects of in utero exposure to antiretroviral drugs (ARV...
Uninfected children born to HIV-infected women are exposed antenatally to antiretroviral therapy, bu...
With expanded HIV treatment and prevention programmes, most infants born to HIV-positive women are u...
We analyzed the development of nevirapine (NVP) resistance in human immunodeficiency virus type 1 (H...
SummaryBackgroundNevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exp...
Background Nevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exposed ...
Latest World Health Organization guidelines recommend weight-based nevirapine prophylaxis for all HI...
Daily nevirapine (NVP) prophylaxis to HIV-exposed infants significantly reduces breast-milk HIV tran...
International audienceBackgroundThe tolerance of antiretroviral drugs in infants must be carefully e...
Background: The World Health Organization HIV guidelines recommend either infant zidovudine (ZDV) or...
Abstract Background India has among the highest rates of infant malnutrition. Few studies investigat...
Daily nevirapine (NVP) prophylaxis to HIV-exposed infants significantly reduces breast-milk HIV tran...
Data from a prospective multisite cohort study were used to examine the effect of HIV exposure, untr...
Background: India has among the highest rates of infant malnutrition. Few studies investigating the ...
Assess nevirapine (NVP) resistance in infants who became infected in the three arms of the Breastfee...
BACKGROUND There are concerns about the effects of in utero exposure to antiretroviral drugs (ARV...
Uninfected children born to HIV-infected women are exposed antenatally to antiretroviral therapy, bu...
With expanded HIV treatment and prevention programmes, most infants born to HIV-positive women are u...
We analyzed the development of nevirapine (NVP) resistance in human immunodeficiency virus type 1 (H...